- Home
- PPL vs PODD Comparison
PPL vs PODD Comparison
Compare PPL & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPL | PODD |
|---|---|---|
| Founded | 1920 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 22.1B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | PPL | PODD |
|---|---|---|
| Price | $34.08 | $304.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $40.11 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 7.1M | 765.6K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | ★ 32.44 | N/A |
| EPS | 1.47 | ★ 3.45 |
| Revenue | ★ $8,979,000,000.00 | $2,521,800,000.00 |
| Revenue This Year | $7.55 | $32.55 |
| Revenue Next Year | $5.11 | $20.39 |
| P/E Ratio | ★ $23.03 | $88.24 |
| Revenue Growth | 8.42 | ★ 27.11 |
| 52 Week Low | $31.22 | $230.05 |
| 52 Week High | $38.27 | $354.88 |
Technical Indicators
Market Signals| Indicator | PPL | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 26.83 | 40.94 |
| Support Level | $35.12 | $303.20 |
| Resistance Level | $36.87 | $317.34 |
| Average True Range (ATR) | 0.61 | 13.12 |
| MACD | -0.25 | -2.82 |
| Stochastic Oscillator | 0.16 | 3.14 |
Price Performance
Historical ComparisonAbout PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.